Lakefront Biotherapeutics American Depositary Shares
LKFTStock
$29.01−2.17%52W
Market Cap$1.90B
P/E5.21x
Div yield—
Beta0.40
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-21.35%
Price vs S&P 500 (4W)7.06%
VGM Score65.01
Market Capitalization$1.90B
P/E Ratio (Annual)5.21x
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
2.61
2.61
2.61
2.61
Industry Peers — Pharmaceuticals(557)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
LKFTLakefront Biotherapeutics American Depositary Shares | A | B | C | $29.01 |
| LLYEli Lilly & Co. | D | B | B | $1117.26 |
| JNJJohnson & Johnson | D | C | C | $241.00 |
| ABBVABBVIE INC. | D | C | B | $234.89 |
| MRKMerck & Co., Inc. | C | C | B | $120.60 |
| NVSNovartis AG | C | C | C | $153.12 |
| AZNAstraZeneca PLC | C | B | C | $183.02 |
| NVONovo-Nordisk A/S | C | B | C | $47.41 |
| ABTAbbott Laboratories | C | C | D | $90.49 |
| PFEPfizer Inc. | B | C | D | $24.04 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $475.20 |
About
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.